Concepedia

Publication | Open Access

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

DOIFull Paper Access

1.5K

Citations

34

References

2012

Year

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter Higgins, Jan Wehkamp, Brian G. Feagan, Michael Yao, Marek Karczewski,
Gut

Abstract

This trial was registered at ClinicalTrial.gov with the number NCT01009281.

References

YearCitations

Page 1